Skip to main content

Peer Review reports

From: Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study

Original Submission
15 Sep 2024 Submitted Original manuscript
25 Sep 2024 Author responded Author comments - Chuandong Cheng
Resubmission - Version 2
25 Sep 2024 Submitted Manuscript version 2
27 Nov 2024 Reviewed Reviewer Report
3 Dec 2024 Reviewed Reviewer Report
18 Dec 2024 Author responded Author comments - Chuandong Cheng
Resubmission - Version 3
18 Dec 2024 Submitted Manuscript version 3
25 Dec 2024 Reviewed Reviewer Report
4 Jan 2025 Reviewed Reviewer Report
7 Jan 2025 Author responded Author comments - Chuandong Cheng
Resubmission - Version 4
7 Jan 2025 Submitted Manuscript version 4
9 Jan 2025 Author responded Author comments - Chuandong Cheng
Resubmission - Version 5
9 Jan 2025 Submitted Manuscript version 5
29 Jan 2025 Author responded Author comments - Chuandong Cheng
Resubmission - Version 6
29 Jan 2025 Submitted Manuscript version 6
14 Feb 2025 Reviewed Reviewer Report
21 Feb 2025 Reviewed Reviewer Report
28 Feb 2025 Reviewed Reviewer Report
9 Mar 2025 Author responded Author comments - Chuandong Cheng
Resubmission - Version 7
9 Mar 2025 Submitted Manuscript version 7
13 Mar 2025 Reviewed Reviewer Report - Bernardo Cacho Diaz
18 Mar 2025 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
19 Mar 2025 Editorially accepted
10 Apr 2025 Article published 10.1186/s12885-025-13979-3

You can find further information about peer review here.

Back to article page